Covering: up to 2017 The overwhelming majority of antibiotics in clinical use originate from
Gram-positive Actinobacteria. In recent years, however, Gram-negative bacteria have …

Addressing the pressing issues of increased food demand, declining crop productivity under
varying agroclimatic conditions, and the deteriorating soil health resulting from the overuse …

Natural products (NPs) from microorganisms have been important sources for discovering
new therapeutic and chemical entities. While their corresponding biosynthetic gene clusters …

Bacteria produce antimicrobial compounds to compete for nutrients and space in a particular
habitat. Antagonistic interactions can be evaluated by several methodologies including the …

The majority of clinically used antibiotics originate from bacteria. As the need for new
antibiotics grows, large-scale genome sequencing and mining approaches are being used …

Background Andrimid is reported to be a novel kind of polyketide-nonribosomal peptide
hybrid product (PK-NRPs) that inhibits fatty acid biosynthesis in bacteria. Considering its …

To determine how bacterial communities succeed after the initial attachment of the bacterial
biofilm adhesion using 16S rDNA meta-barcoding in plates coated with copper-based anti …

Abstract Indole‐3‐acetic acid (IAA) is emerging as a key intra‐and inter‐kingdom signal
molecule that modulates a wide range of processes of importance during plant …

Antimicrobial resistance is a worldwide health crisis for which new antibiotics are needed.
One strategy for antibiotic discovery is identifying unique antibiotic biosynthetic gene …

The LysR-type transcriptional regulators (LTTRs) are DNA-binding proteins present in
bacteria, archaea, and in algae. Knowledge about their distribution, abundance, evolution …